Use of 18F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization
Min Jin Kim, Young Seok Kim, Youn Hee Cho, Hee Yoon Jang, Jeong-Yeop Song, Sae Hwan Lee, Soung Won Jeong, Sang Gyune Kim, Jae Young Jang, Hong Su Kim, Boo Sung Kim, Won Hyung Lee, Jung Mi Park, Jae Myung Lee, Min Hee Lee, Deuk Lin Choi
Korean J Intern Med. 2015;30(3):308-315. Published online 2015 Apr 29 DOI: https://doi.org/10.3904/kjim.2015.30.3.308
Citations to this article as recorded by 
18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies
Gopinath Gnanasegaran, Kanhaiyalal Agrawal, Simon Wan
PET Clinics.2022; 17(3): 369. CrossRef
Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma
Hwang Sik Shin, Sae Hwan Lee, Baek Gyu Jun, Hong Soo Kim, Seong Hee Kang, Ji Young Park, Soo In Choi, Gab Jin Cheon, Young Don Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Ki Tae Suk, Dong Joon Kim, In Young Jo, Yong
European Journal of Gastroenterology & Hepatology.2022; 34(11): 1187. CrossRef
18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
Arno Kornberg, Helmut Friess
Therapeutic Advances in Gastroenterology.2019;[Epub] CrossRef
Emerging role of18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee
World Journal of Gastroenterology.2019; 25(11): 1289. CrossRef
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver
Siavash Mehdizadeh Seraj, Cyrus Ayubcha, Mahdi Zirakchian Zadeh, Abass Alavi, Stephen J. Hunt
PET Clinics.2019; 14(4): 419. CrossRef
18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
Pil Soo Sung, Hye Lim Park, Keungmo Yang, Seawon Hwang, Myeong Jun Song, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ie Ryung Yoo, Si Hyun Bae
European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(3): 384. CrossRef
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman
European Radiology.2018; 28(12): 5356. CrossRef
Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
Baek Gyu Jun, Sang Gyune Kim, Young Don Kim, Gab Jin Cheon, Koon Hee Han, Jeong-Ju Yoo, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Suyeon Park, Hong Soo Kim, Gianfranco D. Alpini
PLOS ONE.2018; 13(10): e0206381. CrossRef
Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma
Paul Blanc-Durand, Axel Van Der Gucht, Mario Jreige, Marie Nicod-Lalonde, Marina Silva-Monteiro, John O. Prior, Alban Denys, Adrien Depeursinge, Niklaus Schaefer
Oncotarget.2018; 9(4): 4549. CrossRef
Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma
Jeong Won Lee, Sang Hyun Hwang, Do Young Kim, Kwang-Hyub Han, Mijin Yun
Clinical Nuclear Medicine.2017; 42(1): e35. CrossRef
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation
Chun-Yi Lin, Chiung-Wei Liao, Lu-Yen Chu, Kuo-Yang Yen, Long-Bin Jeng, Cheng-Nan Hsu, Cheng-Li Lin, Chia-Hung Kao
Clinical Nuclear Medicine.2017; 42(4): e183. CrossRef
Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection
Kyung Jin Cho, Nam Kyu Choi, Min Ho Shin, A Ri Chong
Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(4): 194. CrossRef
Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv
Abdominal Radiology.2016; 41(1): 33. CrossRef
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization
Yazan Abuodeh, Arash O Naghavi, Kamran A Ahmed, Puja S Venkat, Youngchul Kim, Bela Kis, Junsung Choi, Benjamin Biebel, Jennifer Sweeney, Daniel A Anaya, Richard Kim, Mokenge Malafa, Jessica M Frakes, Sarah E Hoffe, Ghassan El-Haddad
World Journal of Gastroenterology.2016; 22(47): 10406. CrossRef
Prognostic Significance of18F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study
Jeong Won Lee, Jin Kyoung Oh, Yong An Chung, Sae Jung Na, Seung Hyup Hyun, Il Ki Hong, Jae Seon Eo, Bong-Il Song, Tae-sung Kim, Do Young Kim, Seung Up Kim, Dae Hyuk Moon, Jong Doo Lee, Mijin Yun
Journal of Nuclear Medicine.2016; 57(4): 509. CrossRef
Transcatheter arterial chemoembolization as an examination method for hepatocellular carcinoma undetected by B-mode ultrasound, computed tomography and digital subtratcion angiography: A case report
ZONGQUAN XU, CHEN YU, SHUFANG WANG, GUOHUI XU
Oncology Letters.2015; 10(3): 1759. CrossRef